JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 131 filers reported holding JOUNCE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 5.36 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,975,000 | -70.4% | 981,928 | -33.7% | 0.25% | -67.5% |
| Q1 2022 | $10,057,000 | -23.9% | 1,481,219 | -6.4% | 0.76% | -1.2% |
| Q4 2021 | $13,216,000 | +179.1% | 1,582,777 | +148.3% | 0.77% | +175.7% |
| Q3 2021 | $4,735,000 | +11.5% | 637,347 | +2.0% | 0.28% | +14.3% |
| Q2 2021 | $4,248,000 | -19.2% | 624,756 | +22.1% | 0.24% | -22.5% |
| Q1 2021 | $5,256,000 | -18.9% | 511,822 | -44.7% | 0.32% | -18.1% |
| Q4 2020 | $6,477,000 | – | 925,280 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 9,200,349 | $64,402,000 | 44.86% |
| TRV GP III, LLC | 3,048,780 | $21,342,000 | 1.83% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 406,665 | $2,847,000 | 1.65% |
| Sofinnova Investments, Inc. | 925,280 | $6,477,000 | 0.39% |
| Omega Fund Management, LLC | 334,965 | $2,345,000 | 0.35% |
| Yorktown Management & Research Co Inc | 49,200 | $344,000 | 0.31% |
| Woodline Partners LP | 940,902 | $6,586,000 | 0.18% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 51,000 | $357,000 | 0.09% |
| HORIZON FINANCIAL SERVICES, LLC | 12,005 | $84,000 | 0.08% |
| Gyon Technologies Capital Management, LP | 26,893 | $188,000 | 0.06% |